Letter of Intent: Circular Health Limited to Enhance ECG Smart Ring with AI-Powered Signal Clarity with multi‑year, per‑user SaaS license targeting commercial launch by September 2025. Global growth ...

The electrocardiogram (ECG) remains a cornerstone in cardiovascular diagnostics, yet its clinical utility is often compromised by signal distortions introduced during acquisition. Contemporary ...

A dynamic ECG reporting engine that supports clinical workflows with customizable components and adaptable output structures These patents strengthen AIML's position in the growing field of ...

Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield™ and CardioYield™. Reinforces competitive advantage as the Company advances ...

Pilot Evaluation: Toronto Heart Centre to conduct comparative testing of CardioYield™ for enhanced Holter ECG analysis and reporting efficiency. Clinical Workflow Impact: Study to measure time savings ...

Please provide your email address to receive an email when new articles are posted on . Algorithms to improve ECG interpretability received FDA clearance. The solution is designed to reduce noise ...

This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration. Partnership ...

Peter Kendall, Director, President & Chief Commercialization Officer, AIML"These filings represent more than technical protection-they signal our readiness to commercialize at scale. With a defensible ...

TORONTO, ON / ACCESS Newswire / November 11, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leader in AI-powered physiological signal interpretation, is ...

Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield and CardioYield. Reinforces competitive advantage as the Company advances ...